- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02936336
The Effect of Exercise Intervention on the Community's Older Adults
11 mei 2018 bijgewerkt door: Robert Wen-Wei Hsu, Chang Gung Memorial Hospital
The Effect of Exercise Intervention on the Physical Fitness, Bone Mineral Density and Health-related Quality of Life in the Community's Older Adults
Osteoporosis is a serious global health problem, second only to cardiovascular disease.
Osteoporosis is the most common metabolic bone disease in the elderly population, characterized by loss of bone mineral density (BMD) and continuous destruction of bone microstructure, especially in postmenopausal women.
It gives rise to bone fragility and fracture risk.
Moreover, as people grow older, falls frequently occur with high severity, and nearly 35% to 45% of persons aged 65 or older fall at least once a year.
Osteoporotic fractures increase mortality, morbidity, chronic pain, and the cost of social care and it decreases the quality of life.
Here, investigators plan to perform different exercise interventions such as circuit exercise, aerobic dance and Tai Chi on the community's older adults to evaluate whether exercise intervention could improve the bone mineral density, physical fitness, muscle strength or quality of life.
Studie Overzicht
Studietype
Ingrijpend
Inschrijving (Werkelijk)
411
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Pizi, Taiwan, 613
- Sports Medicine Center, Chang Gung Memorial Hospital
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
45 jaar tot 85 jaar (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Being >45 years-of-age,
- Healthy and physically independent.
Exclusion Criteria:
- The exclusion criteria were individuals on hormone replacement therapy and those with cognitive impairment, progressive debilitating conditions, bone fractures, or any medical contraindications to administering the fitness assessment.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Geen tussenkomst: Control
without exercise intervention
|
|
Experimenteel: Exercise
Subjects with circuit exercise, aerobic dance, or Tai Chi exercise intervention.
|
circuit exercise, aerobic dance and Tai Chi exercise
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change from baseline bone mineral density
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Bone mineral density measurement is measured by dual-energy x-ray absorptiometry (DXA).
Measurements are made over the lumbar spine and over the upper part of the hip and the measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change from baseline elbow muscle strength
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of elbow were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Change from baseline shoulder muscle strength
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of shoulder were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Change from baseline hip muscle strength
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of hip were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Change from baseline knee muscle strength
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of knee were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Change from baseline SF-36 questionnaire assessment
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower score the more disability.
The higher the score the less disability.
Eight sections including physical function, role limitation due to physical problems, bodily pain, general health, vitality, social functioning, role limitation due to emotional problems, and mental health.
Additionally, the eight health domains can be used to provide a physical component summary and mental component summary score.
The outcome measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
High-density lipoprotein from blood sample
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
High-density lipoprotein are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Triglyceride from blood sample
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Triglyceride are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Fasting blood glucose from blood sample
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Fasting blood glucose are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Blood pressure
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Diastolic and systolic blood pressure are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Weight parameters of the subjects
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Weight (kg) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Height parameters of the subjects
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Height (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Waistline parameters of the subjects
Tijdsspanne: Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Waistline (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Robert Wen-Wei HSU, MD, Sports Medicine Center, Chang Gung Memorial Hospital, Chiayi
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 november 2009
Primaire voltooiing (Werkelijk)
1 december 2013
Studie voltooiing (Werkelijk)
1 december 2013
Studieregistratiedata
Eerst ingediend
13 oktober 2016
Eerst ingediend dat voldeed aan de QC-criteria
14 oktober 2016
Eerst geplaatst (Schatting)
18 oktober 2016
Updates van studierecords
Laatste update geplaatst (Werkelijk)
14 mei 2018
Laatste update ingediend die voldeed aan QC-criteria
11 mei 2018
Laatst geverifieerd
1 mei 2018
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- CMRPG690111-3;CMRPG6A0421-22
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
ONBESLIST
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .